CA
NZ
UK
AU
IND
US
● Omeros fell Friday after the CHMP kept its negative opinion on narsoplimab following re-examination.
● It will pursue named-patient access in Europe instead.
● The drop came 11 days after a jump on an EpiSign and Geneyx partnership.
● No closing move for Praxis shares was reported on Friday.
● No company announcement, filing or analyst action on Repligen was reported.
Iambic Therapeutics Inc. (NASDAQ:IAM) ranked among the strongest gainers in the US market on Friday, October 16, 2026, closing at $23.81 for a daily gain of 25.91%.
Strata Critical Medical, Inc. (NASDAQ:SRTA) closed at $4.54 on Friday, October 16, 2026, up 4.61% on the day. The small-cap advanced during a session in which the broad market fell, and the move is best explained by the trading characteristics of a lightly traded …
Alaunos Therapeutics, Inc. (NASDAQ:TCRT) moved sharply higher on Friday, October 16, 2026, closing at $2.630, a gain of 20.64% for the session. The advance came on a day when the broad US market was lower, with the Nasdaq Composite down 2.14% and the S&P …
Jaguar Health, Inc. (NASDAQ:JAGX) delivered one of the more eye-catching single-day advances of the US trading session on Friday, October 16, 2026, with a gain of 53.59%. The move ran counter to the dominant theme of the day, which was a steep selloff in …
Picard Medical, Inc. (NYSE American:PMI) was a prominent gainer in the US session on Friday, October 16, 2026, closing at $12.75, up 27.50%. The advance came on a day dominated by a selloff in technology, artificial-intelligence and semiconductor shares, with the Nasdaq Composite down …
Please wait processing your request...